Prolight Diagnostics strengthens management

Today, Prolight Diagnostics announces that it has hired Karl Bullen as Head of Manufacturing in its subsidiary Psyros Diagnostics to ensure the company's internal competence in manufacturing. "It gives us immense satisfaction that our company can attract such senior and competent staff. We consider it a testament to the strong market we see for our […]

Annual General Meeting of Prolight Diagnostics AB (publ) on 20 May 2022

The Annual General Meeting (AGM) of Prolight Diagnostics AB (publ) took place on Friday 20 May 2022. The AGM was conducted by way of postal voting, without the physical presence of shareholders. Full information regarding the decisions of the AGM is available on the companys website, www.prolightdiagnostics.se.  Resolution regarding the adoption of the income statement […]

Prolight Diagnostics AB acquires Psyros Diagnostics Ltd

Prolight Diagnostics AB has today signed an agreement to acquire UK-based Psyros Diagnostics Ltd for 65 MSEK (ca. £5.25M). Psyros Diagnostics has developed a ground-breaking single-molecule counting Point-of-Care (POC) technology. This patent-pending and multiplex-capable technology enables the measurement of biomarkers at extremely low concentrations (femtomolar 10-15) in approximately 10 minutes or less. "To our knowledge, […]